It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Change in eating habits in early breast cancer (EBC) patients during chemotherapy has been poorly studied in the literature. The primary aim of this study was to prospectively evaluate food preferences and weight change in EBC patients before and after adjuvant chemotherapy. From April 2014 to June 2018, 205 EBC patients underwent a dietary assessment according to the following timeline: baseline evaluation (one week before starting chemotherapy, T0); first follow-up (approximately 2–3 months after starting chemotherapy, T1); final follow-up (one week after chemotherapy end, T2). A statistically significant reduction of the following foods was reported after the start of chemotherapy: pasta or rice, bread, breadsticks/crackers, red meat, fat and lean salami, fresh and aged cheese, milk, yogurt, added sugar, soft drinks, alcoholic beverages (wine, beer, and schnapps), and condiments (oil and butter). Conversely, fruit consumption consistently increased. As a result of these changes, a Healthy Eating Index (HEI) specifically developed for this study and suggestive of a balanced diet, significantly increased. Body weight did not increase, despite reduction in physical activity. This prospective study shows that EBC patients tend to adopt “healthier dietary patterns” during adjuvant chemotherapy, leading to a non-change in weight, despite reduction in physical activity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 ASST-Spedali Civili of Brescia, Medical Oncology Department, Brescia, Italy (GRID:grid.412725.7); ASST-Spedali Civili of Brescia, SSVD Breast Unit, Brescia, Italy (GRID:grid.412725.7)
2 ASST-Spedali Civili of Brescia, Medical Oncology Department, Brescia, Italy (GRID:grid.412725.7)
3 ASST-Spedali Civili of Brescia, SSVD Breast Unit, Brescia, Italy (GRID:grid.412725.7)
4 University of Brescia, Department of Clinical and Experimental Sciences, Brescia, Italy (GRID:grid.7637.5) (ISNI:0000000417571846)
5 University of Brescia, Department of Clinical and Experimental Sciences, Brescia, Italy (GRID:grid.7637.5) (ISNI:0000000417571846); ASST-Spedali Civili of Brescia, SSVD Gastroenterology, Brescia, Italy (GRID:grid.412725.7)